- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783832298746
- Dimensions
-
21 cm, 275 g
- Extent
-
IV, VI, 171 S.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Zugl.: Hamburg, Univ., Diss., 2010
- Keyword
-
Arzneimittelentwicklung
Screening
Computational chemistry
Indizierung
Moleküldeskriptor
Physikalisch-chemische Eigenschaft
Moleküldeskriptor
Computational chemistry
Physikalisch-chemische Eigenschaft
Screening
Arzneimittelentwicklung
Indizierung (Informatik)
Computersimulation
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:01 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Schlosser, Jochen
- Shaker
Time of origin
- 2011
Other Objects (12)
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Decomposing compounds enables reconstruction of interaction fingerprints for structure‑based drug screening
A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing
Structure-based design of hyaluronidase inhibitors
Screening and structure-based design of novel ligands for FabF and KPC-2
In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
Structure-Based Partitioning of Semantic Web Ontologies
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Decomposing compounds enables reconstruction of interaction fingerprints for structure‑based drug screening
A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing
Structure-based design of hyaluronidase inhibitors
Screening and structure-based design of novel ligands for FabF and KPC-2
In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
Structure-Based Partitioning of Semantic Web Ontologies
Structure-Based Virtual Screening Using Index Technology
Analysis of ligand- and structure-based virtual screening data
Structural Analysis of 20S Proteasome and Development of Structure-Based Virtual Screening Methods
Structural analysis of 20S proteasome and development of structure-based virtual screening methods
Controlling Hyperglycemia: Discovery of Novel Small α-Amylase Inhibitors Using Structure-Based Virtual Screening
Structure‐based screening of tetrazolylhydrazide inhibitors versus KDM4 histone demethylases
Decomposing compounds enables reconstruction of interaction fingerprints for structure‑based drug screening
A novel class of Schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in vitro testing
Structure-based design of hyaluronidase inhibitors
Screening and structure-based design of novel ligands for FabF and KPC-2
In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions